News
Natalie Schnaitmann discusses the importance of self-advocacy and access to second opinions when symptoms are dismissed among ...
Let’s get straight to the point: a good nurse can change your experience with cancer and cancer treatment.
The first patient has been dosed in the phase 3 TERZO trial of Copiktra for relapsed or refractory nodal T-follicular helper ...
It is important to understand why it is vital that patients and survivors of cancer take steps to reduce the body’s burden ...
Dr. Jared Weiss walks patients through the therapeutic potential viability of intratumoral therapies among those with lung ...
Using a 14-gene test to guide chemotherapy significantly improved disease-free survival in patients with early nonsquamous ...
How artificial intelligence is being used to augment the work of experts treating patients with prostate cancer.
The dual-targeting CAR T-cell therapy KITE-363 showed positive response rates and manageable side effects in relapsed or ...
Adding Zyprexa to ondansetron cut nausea and vomiting safely in abdominal/pelvic radiation with low-emetogenic capecitabine.
The FDA granted orphan drug designation to MVdeltaC, a measles virus-based immunotherapy, for pleural mesothelioma, ...
Iopofosine-131 received FDA breakthrough status for relapsed or refractory Waldenstrom macroglobulinemia, showing strong ...
Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results